{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:15Z","timestamp":1786654035305,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 CA227101"],"award-info":[{"award-number":["R37 CA227101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118252","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:50:35Z","timestamp":1783781435000},"page":"118252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BiP-engaging xanthones from the mangosteen (Garcinia mangostana) induce androgen receptor degradation in prostate cancer cells"],"prefix":"10.1016","volume":"252","author":[{"given":"Pariksha","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robel","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5489-2372","authenticated-orcid":false,"given":"Jeremy J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.118252_b0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118252_b0010","doi-asserted-by":"crossref","DOI":"10.1177\/17562872231182219","article-title":"Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer","volume":"15","author":"Zarrabi","year":"2023","journal-title":"Ther. Adv. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118252_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41391-018-0079-0","article-title":"Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations","volume":"22","author":"Crawford","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.118252_b0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0090-4295(00)00793-7","article-title":"Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making","volume":"56","author":"Oefelein","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.bcp.2026.118252_b0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of Advanced Prostate Cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bcp.2026.118252_b0030","doi-asserted-by":"crossref","unstructured":"Antonarakis, E. S., Lu, C., Wang, H., Luber, B., Nakazawa, M., Roeser, J. C., Chen, Y., Mohammad, T. A., Chen, Y., Fedor, H. L., Lotan, T. L., Zheng, Q., De Marzo, A. M., Isaacs, J. T., Isaacs, W. B., Nadal, R., Paller, C. J., Denmeade, S. R., Carducci, M. A.,\u2026Luo, J. (2014). AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med, 371(11), 1028-1038. https:\/\/doi.org\/10.1056\/NEJMoa1315815.","DOI":"10.1056\/NEJMoa1315815"},{"key":"10.1016\/j.bcp.2026.118252_b0035","doi-asserted-by":"crossref","unstructured":"de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Jr., Saad, F., Staffurth, J. N., Mainwaring, P., Harland, S., Flaig, T. W., Hutson, T. E., Cheng, T., Patterson, H., Hainsworth, J. D., Ryan, C. J.,\u2026Scher, H. I. (2011). Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med, 364(21), 1995-2005. https:\/\/doi.org\/10.1056\/NEJMoa1014618.","DOI":"10.1056\/NEJMoa1014618"},{"issue":"13","key":"10.1016\/j.bcp.2026.118252_b0040","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118252_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072118","article-title":"\u03b1-Mangostin promotes in vitro and in vivo degradation of androgen receptor and AR-V7 splice variant in prostate cancer cells","volume":"15","author":"Nauman","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118252_b0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s10020-023-00706-6","article-title":"Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review","volume":"29","author":"Akinyemi","year":"2023","journal-title":"Mol. Med."},{"issue":"49","key":"10.1016\/j.bcp.2026.118252_b0055","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.0807691105","article-title":"Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78\/BiP in prostate epithelium","volume":"105","author":"Fu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bcp.2026.118252_b0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","article-title":"The glucose-regulated proteins: stress induction and clinical applications","volume":"26","author":"Lee","year":"2001","journal-title":"Trends Biochem. Sci"},{"issue":"20","key":"10.1016\/j.bcp.2026.118252_b0065","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1158\/0008-5472.CAN-07-0625","article-title":"The unfolded protein response regulator GRP78\/BiP as a novel target for increasing chemosensitivity in malignant gliomas","volume":"67","author":"Pyrko","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021566","article-title":"Endoplasmic reticulum stress and cancer: could unfolded protein response be a druggable target for cancer therapy?","volume":"24","author":"Bonsignore","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.15430\/JCP.2014.19.2.75","article-title":"Endoplasmic reticulum stress and cancer","volume":"19","author":"Yadav","year":"2014","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.bcp.2026.118252_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115792","article-title":"Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy","volume":"261","author":"Guo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118252_b0085","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1074\/jbc.REV118.002810","article-title":"Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones","volume":"294","author":"Mayer","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118252_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106630","article-title":"Mangosteen for malignancy prevention and intervention: current evidence, molecular mechanisms, and future perspectives","volume":"188","author":"Kalick","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.118252_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106032","article-title":"The purple mangosteen (Garcinia mangostana): defining the anticancer potential of selected xanthones","volume":"175","author":"Nauman","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/bgr291","article-title":"\u03b1-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth","volume":"33","author":"Johnson","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bcp.2026.118252_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbrc.2014.09.054","article-title":"Inhibition of CHOP accentuates the apoptotic effect of \u03b1-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells","volume":"453","author":"Li","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.bcp.2026.118252_b0110","article-title":"Selective modulation of endoplasmic reticulum stress markers in prostate cancer cells by a standardized mangosteen fruit extract","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2026.118252_b0115","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/mnfr.201600037","article-title":"Gartanin, an isoprenylated xanthone from the mangosteen fruit (Garcinia mangostana), is an androgen receptor degradation enhancer","volume":"60","author":"Li","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.118252_b0120","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1080\/14786419.2020.1777413","article-title":"Inhibition of CDK2\/CyclinE1 by xanthones from the mangosteen (Garcinia mangostana): a structure-activity relationship study","volume":"35","author":"Nauman","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.118252_b0125","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2174\/138945012804545524","article-title":"Single dose oral pharmacokinetic profile of \u03b1-mangostin in mice","volume":"13","author":"Ramaiya","year":"2012","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14302\/issn.2379-7835.ijn-19-2845","article-title":"Structure activity relationship of xanthones for inhibition of Cyclin Dependent Kinase 4 from mangosteen (Garcinia mangostana L.).","volume":"4","author":"Vemu","year":"2019","journal-title":"Int. J. Nutr."},{"key":"10.1016\/j.bcp.2026.118252_b0135","doi-asserted-by":"crossref","unstructured":"Verma, N., Pandit, S., Kumar, A., Yadav, G., Giri, S. K., Lahiri, D., Kari, Z. A., Prasad, R., & KanuPriya. (2022). Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana. Appl Biochem Biotechnol, 194(10), 4724-4744. https:\/\/doi.org\/10.1007\/s12010-022-04031-2.","DOI":"10.1007\/s12010-022-04031-2"},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2026.118252_b0145","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(86)90746-4","article-title":"An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein","volume":"46","author":"Munro","year":"1986","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118252_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020382","article-title":"GRP78 in Glioma Progression and Therapy: implications for Targeted Approaches","volume":"13","author":"Yang","year":"2025","journal-title":"Biomedicines"},{"issue":"22","key":"10.1016\/j.bcp.2026.118252_b0160","doi-asserted-by":"crossref","first-page":"E2865","DOI":"10.1073\/pnas.1506692112","article-title":"Substrate-binding domain conformational dynamics mediate Hsp70 allostery","volume":"112","author":"Zhuravleva","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.bcp.2026.118252_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166963","article-title":"The ER chaperones BiP and Grp94 regulate the formation of insulin-like growth factor 2 (IGF2) oligomers","volume":"433","author":"Jin","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118252_b0170","doi-asserted-by":"crossref","first-page":"9260","DOI":"10.1158\/0008-5472.CAN-06-1586","article-title":"(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78","volume":"66","author":"Ermakova","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.118252_b0175","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3390\/nu5083163","article-title":"Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence","volume":"5","author":"Gutierrez-Orozco","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118252_b0180","article-title":"Prenylated xanthones from mangosteen (Garcinia mangostana) target oxidative mitochondrial respiration in cancer cells","volume":"179","author":"El Gaafary","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bcp.2026.118252_b0185","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/156652411797536679","article-title":"Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs","volume":"11","author":"Shan","year":"2011","journal-title":"Curr. Mol. Med."},{"issue":"45","key":"10.1016\/j.bcp.2026.118252_b0190","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/onc.2011.637","article-title":"AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118252_b0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gene.2017.03.005","article-title":"HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum","volume":"618","author":"Wang","year":"2017","journal-title":"Gene"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:15:43Z","timestamp":1786652143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0006295226005915"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118252","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BiP-engaging xanthones from the mangosteen (Garcinia mangostana) induce androgen receptor degradation in prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118252"}}